SV Life Sciences Fund I

SVLSF I closed in 1994 with total commitments of $100 million.

As at 31 March 2010, SVLSF I had invested $123 million in 31 portfolio companies.

To go to individual portfolio companies websites please click on company logo.

General Surgical Innovations: US - Exited

First investment: 1995 - Early Stage

General Surgical Innovations is a minimally invasive approach to hernia repair and incontinence (purchased by United States Surgical).

---

Genosis: UK - Exited

First investment: 1999 - Start Up

Genosis has developed home use diagnostic devices to assess fertility in couples of
childbearing age. Genosis’ products - Fertell, which provide both male and female tests, are
available over the counter in the UK and the US and provide couples with the tools required to
assess their fertility in the privacy of their homes.

---

Leica Microsystems: Germany - Exited

First investment: 1998 - Buyout

Leica Manufactured and marketed microscopes and neurosurgical equipment.

---

MedNova: Ireland - Exited

First investment: 1996 - Start Up

MedNova was a device for interventional radiology and cardiology.

---

Micromass: UK - Exited

First investment: 1996 - Buyout

Micromass was a minimally invasive approach to hernia repair and incontinence (purchased by Waters).

---

MicroMed: US - Exited

First investment: 1998 - Early Stage

MicroMed based in Houston, TX, has developed an implantable pump for use as a Left Ventricular Assist Device (LVAD) to aid the heart’s pumping action in patients suffering from
congestive heart failure.

---

Nexan: UK - Exited

First investment: 1996 - Start Up

Nexan was a remote telemonitoring devices.

---

Orthovita: US - Exited

First investment: 1997 - Early Stage

Orthovita was a novel bone substitute materials company.

---

Sirona Dental Systems: Germany - Exited

First investment: 1997 - Buyout

Sirona was a dental equipment manufacturer.

---